Lawmakers rushed into the drug pricing arena this week as they revived a bundle of legislation and oversight talks, signaling they want to put manufacturers in the hot seat when it comes to addressing health care costs. Medicare negotiation was at the forefront of Democratic messaging with an unexpected Republican boost. (Susannah Luthi, Modern Healthcare)
